Ticker Symbol | Entity Name | Employer Id | As Of Date | Profile Url | Name | Website | Company Type | Industry | Active Status | Employer Status | Headquarters City | Year Founded | Rating: Overall | Rating: CEO (%) | Rating: Business Outlook (%) | Rating: Recommend (%) | Rating: Compensation & Benefits | Rating: Culture & Values | Rating: Career Opportunities | Rating: Diversity and Inclusion | Rating: Work/Life Balance | Rating: Senior Management | Ratings Star 1 Count | Ratings Star 2 Count | Ratings Star 3 Count | Ratings Star 4 Count | Ratings Star 5 Count | Ratings Count | Ratings Diversity and Inclusion Count | Ratings CEO Count | Ratings Star 1 (%) | Ratings Star 2 (%) | Ratings Star 3 (%) | Ratings Star 4 (%) | Ratings Star 5 (%) | Awards Count | Job Count | Review Count | Interview Experience: Positive | Interview Experience: Neutral | Interview Experience: Negative | Interview Channel: Online (%) | Interview Channel: Campus Recruiting | Interview Channel: Recruiter | Interview Channel: Employee Referral | Interview Channel: Staffing Agency | Interview Channel: In-Person | Interview Channel: Other | CEO Profile Image | CEO | Date Added | Date Updated | Company Name | Sector | Industry | CEO Gender | CEO Ethnicity |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:itci | https://www.glassdoor.com?employer_id=267817 | 267817 | May 4th, 2024 12:00AM | Open | Intra-Cellular Therapies | Open | Company - Public | Biotech & Pharmaceuticals | New York, NY | 3.10 | -100% | 48% | 39% | 3.80 | 2.60 | 2.60 | 3.10 | 3.20 | 2.30 | 2.00 | 4.00 | 2.00 | 4.00 | 3.00 | 15.00 | 23.00 | 0.00 | 13.333% | 26.667% | 13.333% | 26.667% | 20% | 0.00 | 29.00 | 1.00 | May 4th, 2024 06:22PM | May 4th, 2024 06:22PM | Intra-Cellular Therapies | Health Care | Pharmaceuticals & Biotechnology | |||||||||||||||||
nasdaq:itci | https://www.glassdoor.com?employer_id=267817 | 267817 | May 3rd, 2024 12:00AM | Open | Intra-Cellular Therapies | Open | Company - Public | Biotech & Pharmaceuticals | New York, NY | 3.10 | -100% | 48% | 39% | 3.80 | 2.60 | 2.60 | 3.10 | 3.20 | 2.30 | 2.00 | 4.00 | 2.00 | 4.00 | 3.00 | 15.00 | 23.00 | 0.00 | 13.333% | 26.667% | 13.333% | 26.667% | 20% | 0.00 | 29.00 | 1.00 | May 3rd, 2024 02:47PM | May 3rd, 2024 02:47PM | Intra-Cellular Therapies | Health Care | Pharmaceuticals & Biotechnology | |||||||||||||||||
nasdaq:itci | https://www.glassdoor.com?employer_id=267817 | 267817 | May 2nd, 2024 12:00AM | Open | Intra-Cellular Therapies | Open | Company - Public | Biotech & Pharmaceuticals | New York, NY | 3.10 | -100% | 48% | 39% | 3.80 | 2.60 | 2.60 | 3.10 | 3.20 | 2.30 | 3.00 | 4.00 | 2.00 | 4.00 | 3.00 | 16.00 | 23.00 | 0.00 | 18.75% | 25% | 12.5% | 25% | 18.75% | 0.00 | 67.00 | 29.00 | 1.00 | May 2nd, 2024 09:37AM | May 2nd, 2024 09:37AM | Intra-Cellular Therapies | Health Care | Pharmaceuticals & Biotechnology | ||||||||||||||||
nasdaq:itci | https://www.glassdoor.com?employer_id=267817 | 267817 | May 1st, 2024 12:00AM | Open | Intra-Cellular Therapies | Open | Company - Public | Biotech & Pharmaceuticals | New York, NY | 3.10 | -100% | 48% | 39% | 3.80 | 2.60 | 2.60 | 3.10 | 3.20 | 2.30 | 3.00 | 4.00 | 2.00 | 4.00 | 3.00 | 16.00 | 23.00 | 0.00 | 18.75% | 25% | 12.5% | 25% | 18.75% | 0.00 | 67.00 | 29.00 | 1.00 | May 1st, 2024 09:13AM | May 1st, 2024 09:13AM | Intra-Cellular Therapies | Health Care | Pharmaceuticals & Biotechnology | ||||||||||||||||
nasdaq:itci | https://www.glassdoor.com?employer_id=267817 | 267817 | Apr 30th, 2024 12:00AM | Open | Intra-Cellular Therapies | Open | Company - Public | Biotech & Pharmaceuticals | New York, NY | 3.10 | -100% | 48% | 39% | 3.80 | 2.60 | 2.60 | 3.10 | 3.20 | 2.30 | 3.00 | 4.00 | 2.00 | 4.00 | 3.00 | 16.00 | 23.00 | 0.00 | 18.75% | 25% | 12.5% | 25% | 18.75% | 0.00 | 67.00 | 29.00 | 1.00 | Apr 30th, 2024 08:02AM | Apr 30th, 2024 08:02AM | Intra-Cellular Therapies | Health Care | Pharmaceuticals & Biotechnology | ||||||||||||||||
nasdaq:itci | https://www.glassdoor.com?employer_id=267817 | 267817 | Apr 29th, 2024 12:00AM | Open | Intra-Cellular Therapies | Open | Company - Public | Biotech & Pharmaceuticals | New York, NY | 3.10 | -100% | 48% | 39% | 3.80 | 2.60 | 2.60 | 3.10 | 3.20 | 2.30 | 3.00 | 4.00 | 2.00 | 4.00 | 3.00 | 16.00 | 23.00 | 0.00 | 18.75% | 25% | 12.5% | 25% | 18.75% | 0.00 | 29.00 | 1.00 | Apr 29th, 2024 09:18AM | Apr 29th, 2024 09:18AM | Intra-Cellular Therapies | Health Care | Pharmaceuticals & Biotechnology | |||||||||||||||||
nasdaq:itci | https://www.glassdoor.com?employer_id=267817 | 267817 | Apr 28th, 2024 12:00AM | Open | Intra-Cellular Therapies | Open | Company - Public | Biotech & Pharmaceuticals | New York, NY | 3.10 | -100% | 48% | 39% | 3.80 | 2.60 | 2.60 | 3.10 | 3.20 | 2.30 | 3.00 | 4.00 | 2.00 | 4.00 | 3.00 | 16.00 | 23.00 | 0.00 | 18.75% | 25% | 12.5% | 25% | 18.75% | 0.00 | 29.00 | 1.00 | Apr 28th, 2024 04:16PM | Apr 28th, 2024 04:16PM | Intra-Cellular Therapies | Health Care | Pharmaceuticals & Biotechnology | |||||||||||||||||
nasdaq:itci | https://www.glassdoor.com?employer_id=267817 | 267817 | Apr 26th, 2024 12:00AM | Open | Intra-Cellular Therapies | Open | Company - Public | Biotech & Pharmaceuticals | New York, NY | 3.10 | -100% | 48% | 39% | 3.80 | 2.60 | 2.60 | 3.10 | 3.20 | 2.30 | 3.00 | 4.00 | 2.00 | 4.00 | 3.00 | 16.00 | 23.00 | 0.00 | 18.75% | 25% | 12.5% | 25% | 18.75% | 0.00 | 29.00 | 1.00 | Apr 26th, 2024 08:03AM | Apr 26th, 2024 08:03AM | Intra-Cellular Therapies | Health Care | Pharmaceuticals & Biotechnology | |||||||||||||||||
nasdaq:itci | https://www.glassdoor.com?employer_id=267817 | 267817 | Apr 25th, 2024 12:00AM | Open | Intra-Cellular Therapies | Open | Company - Public | Biotech & Pharmaceuticals | New York, NY | 3.10 | -100% | 48% | 39% | 3.80 | 2.60 | 2.60 | 3.10 | 3.20 | 2.30 | 3.00 | 4.00 | 2.00 | 4.00 | 3.00 | 16.00 | 23.00 | 0.00 | 18.75% | 25% | 12.5% | 25% | 18.75% | 0.00 | 29.00 | 1.00 | Apr 25th, 2024 06:22PM | Apr 25th, 2024 06:22PM | Intra-Cellular Therapies | Health Care | Pharmaceuticals & Biotechnology | |||||||||||||||||
nasdaq:itci | https://www.glassdoor.com?employer_id=267817 | 267817 | Apr 24th, 2024 12:00AM | Open | Intra-Cellular Therapies | Open | Company - Public | Biotech & Pharmaceuticals | New York, NY | 3.10 | -100% | 48% | 39% | 3.80 | 2.60 | 2.60 | 3.10 | 3.20 | 2.30 | 3.00 | 4.00 | 2.00 | 4.00 | 3.00 | 16.00 | 23.00 | 0.00 | 18.75% | 25% | 12.5% | 25% | 18.75% | 0.00 | 29.00 | 1.00 | Apr 24th, 2024 10:47AM | Apr 24th, 2024 10:47AM | Intra-Cellular Therapies | Health Care | Pharmaceuticals & Biotechnology |